 <h1>Plenaxis Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>abarelix</i></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Interactions</li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about abarelix. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Plenaxis.</p><p><i>Applies to abarelix: intramuscular powder for injection</i></p><h3>Endocrine</h3><p>Endocrine side effects have included hot flushes (79%), sleep disturbance (44%), breast enlargement (30%), and breast pain/nipple tenderness (20%) as pharmacological consequences of androgen deprivation.<sup>[Ref]</sup></p><h3>General</h3><p>General side effects including pain (31%) and fatigue (10%) have been reported.<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Musculoskeletal side effects including back pain (17%) have been reported.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Physicians should carefully consider whether the risks of abarelix (the active ingredient contained in Plenaxis) outweigh the benefits in patients with baseline QTc values &gt;450 msec and in patients taking class IA or class III antiarrhythmic medications.<sup>[Ref]</sup></p><p>Cardiovascular side effects including peripheral edema (15%) and prolongation of the QT interval have been reported.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Gastrointestinal side effects including constipation (15%), diarrhea (11%), and nausea (10%) have been reported.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Nervous system side effects including dizziness (12%) and headache (12%) have been reported.<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Respiratory side effects including upper respiratory tract infection (12%) have been reported.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Genitourinary side effects including dysuria (10%), micturition frequency (10%), urinary retention (10%), and urinary tract infection (10%) have been reported.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>The allergic reaction included urticaria, pruritus, hypotension, and syncope.</p><p></p><p>Immediate-onset reactions have been reported to have occurred following any administration of abarelix (the active ingredient contained in Plenaxis)  including the initial dose.  The cumulative risk for such a reaction increases with the duration of treatment.  </p><p></p><p>Following each injection of abarelix, patients should be observed for at least 30 minutes in the office.  If an allergic reaction associated with hypotension and/or syncope does occur, supportive measures such as leg elevation, oxygen, IV fluids, antihistamines, corticosteroids, and epinephrine should be administered as needed.<sup>[Ref]</sup></p><p>Hypersensitivity side effects including immediate-onset allergic reactions (3.7%), sometimes resulting in hypotension and syncope, have been reported to have occurred after administration of abarelix.<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Hepatic side effects including clinically meaningful increases in serum transaminases have been reported in a small percentage of patients.<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Hematologic side effects including slight decreases in hemoglobin and mean increases in serum triglycerides of approximately 10% have been reported.<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Plenaxis (abarelix)." Praecis Pharmaceuticals Inc, Waltham, MA. </p><h2>More about Plenaxis (abarelix)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: gonadotropin-releasing hormone antagonists</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Prostate Cancer</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>